Financials

News Discussions Technicals Seasonals

4978 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

ReproCELL, Inc. engages in stem cell research. It operates through the following segments: Research Support and Medical. The Research Support segment includes reagents and drug discovery support in the Induced Pluripotent Stem (iPS) cell business. The Medical segment deals with regenerative medicine in the iPS cell business and clinical testing services. The company was founded by Norio Nakatsuji and Hiromitsu Nakauchi on February 26, 2003 and is headquartered in Yokohama, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

4978 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company